Bausch Health考虑出售Bausch + Lomb,以完成企业分离。 Bausch Health considers selling Bausch + Lomb to complete their corporate separation.

一家全球制药公司Bausch Health正在探讨其子公司Bausch + Lomb的可能销售,作为完成分离工作的一部分。 Bausch Health, a global pharmaceutical company, is exploring the potential sale of its subsidiary, Bausch + Lomb, as part of efforts to complete their separation. 该公司董事会已授权管理层考虑这一选择,但没有作出任何决定,销售也得不到保证。 The company’s board has authorized management to consider this option, but no decision has been made, and a sale is not guaranteed. 此举是为了回应最近的市场传闻，Bausch Health 将根据需要分享更多细节。 This move comes in response to recent market rumors, and Bausch Health will share more details as needed.